39763689|t|Strategies to prevent postoperative delirium: a comprehensive evaluation of anesthesia selection and drug intervention.
39763689|a|Postoperative delirium (POD) represents a common neurological complication encountered predominantly among the elderly cohort undergoing surgical intervention for hip fractures. This phenomenon, particularly commonplace in geriatric populations with heightened preoperative risk profiles, pronounced comorbidities, and later stages of lifespan, poses complex clinical challenges. The impact of perioperative pharmacological interventions and anesthetic strategies on POD's emergence cannot be understated, as it may profoundly affect the length of hospital stays, rehabilitation milestones, and the overall mortality hazard. The pharmacotherapeutic landscape for managing POD remains constrained, underscoring the imperative nature of preventive measures. Prudent preoperative risk stratification, meticulous intraoperative neuromonitoring guided by electroencephalographic studies, and a holistic postoperative patient welfare model are cornerstone recommendations in the quest to mitigate POD's incidence. Nonetheless, an extensive exploration into the influence of anesthetic approaches and perioperative medications on the emergence of POD is yet to be satisfactorily charted. Our investigation endeavors to dissect the nexus between anesthetic modalities, perioperative pharmacological interventions, and POD incident rates among the elderly with hip fractures. This study spotlights pivotal determinants of POD in the wake of hip fracture surgery by evaluating and synthesizing data from peer-reviewed sources that adhere to rigorous inclusion criteria. Preliminary studies have revealed that certain anesthesia protocols and perioperative medications may increase the potential incidence of POD, such as higher depth of anesthesia or benzodiazepine use, and the incidence of POD in specific populations, such as patients with higher age, prior history of psychosis, and lower intraoperative oxygen saturation The findings from this study are instrumental in refining strategic perioperative plans tailored for the elderly recipients of hip fracture surgery, aimed at not only diminishing the incidence but also the gravity of POD. Despite these forward steps, the clinical uncertainty concerning the efficacy and safety of the specific drugs and surgical techniques in question remains. These lingering questions underscore the exigency for more extensive, empirically grounded research to consolidate the learnings of this investigation.
39763689	22	44	postoperative delirium	Disease	MESH:D000071257
39763689	120	142	Postoperative delirium	Disease	MESH:D000071257
39763689	144	147	POD	Disease	MESH:D000071257
39763689	169	194	neurological complication	Disease	MESH:D002493
39763689	283	296	hip fractures	Disease	MESH:D006620
39763689	587	590	POD	Disease	MESH:D000071257
39763689	792	795	POD	Disease	MESH:D000071257
39763689	1032	1039	patient	Species	9606
39763689	1111	1114	POD	Disease	MESH:D000071257
39763689	1260	1263	POD	Disease	MESH:D000071257
39763689	1430	1433	POD	Disease	MESH:D000071257
39763689	1472	1485	hip fractures	Disease	MESH:D006620
39763689	1533	1536	POD	Disease	MESH:D000071257
39763689	1552	1564	hip fracture	Disease	MESH:D006620
39763689	1818	1821	POD	Disease	MESH:D000071257
39763689	1861	1875	benzodiazepine	Chemical	MESH:D001569
39763689	1902	1905	POD	Disease	MESH:D000071257
39763689	1939	1947	patients	Species	9606
39763689	1982	1991	psychosis	Disease	MESH:D011618
39763689	2018	2024	oxygen	Chemical	MESH:D010100
39763689	2163	2175	hip fracture	Disease	MESH:D006620
39763689	2253	2256	POD	Disease	MESH:D000071257
39763689	Positive_Correlation	MESH:D001569	MESH:D000071257

